Eagle Pharmaceuticals, Inc.

CIK 827871 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Eagle Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2025SCHEDULE 13G0001412741-25-000006
Aug 14, 2025SCHEDULE 13G/A0001104659-25-078716
Feb 19, 2025SCHEDULE 13G0001104659-25-015192
Feb 19, 2025SCHEDULE 13G/A0001104659-25-015190
Feb 14, 2025SCHEDULE 13G/A0001172661-25-000899
Jan 24, 202515-12G0001104659-25-005983
Dec 9, 2024EFFECT9999999995-24-003701
Dec 2, 20248-K0001104659-24-124589
Nov 27, 2024S-8 POS0001104659-24-123686
Nov 27, 2024RW0001104659-24-123691
Nov 27, 2024S-8 POS0001104659-24-123688
Nov 27, 20248-K0001104659-24-123472
Nov 27, 2024S-8 POS0001104659-24-123684
Nov 27, 2024S-8 POS0001104659-24-123687
Nov 27, 2024S-8 POS0001104659-24-123685
Nov 27, 2024POS AM0001104659-24-123690
Nov 27, 2024S-8 POS0001104659-24-123683
Nov 26, 2024250001104659-24-123086
Nov 19, 202430001415889-24-027278
Nov 15, 20248-K0001104659-24-119783
Nov 14, 2024SC 13G/A0001041062-24-000189
Nov 14, 2024SC 13G/A0001274173-24-000091
Nov 13, 2024NT 10-Q0001104659-24-117303
Nov 12, 20248-K0001104659-24-116329
Nov 12, 2024SC 13G0000950170-24-125060